Literature DB >> 26104418

Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy.

Laura A Magee1, Anouk Pels2, Michael Helewa3, Evelyne Rey4, Peter von Dadelszen5.   

Abstract

OBJECTIVE: This guideline summarizes the quality of the evidence to date and provides a reasonable approach to the diagnosis, evaluation and treatment of the hypertensive disorders of pregnancy (HDP). EVIDENCE: The literature reviewed included the previous Society of Obstetricians and Gynaecologists of Canada (SOGC) HDP guidelines from 2008 and their reference lists, and an update from 2006. Medline, Cochrane Database of Systematic Reviews (CDSR), Cochrane Central Registry of Controlled Trials (CCRCT) and Database of Abstracts and Reviews of Effects (DARE) were searched for literature published between January 2006 and March 2012. Articles were restricted to those published in French or English. Recommendations were evaluated using the criteria of the Canadian Task Force on Preventive Health Care and GRADE.
Copyright © 2014 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blood pressure; Hypertension; Long-term prognosis; Maternal outcome; Perinatal outcome; Preeclampsia; Pregnancy

Year:  2014        PMID: 26104418     DOI: 10.1016/j.preghy.2014.01.003

Source DB:  PubMed          Journal:  Pregnancy Hypertens        ISSN: 2210-7789            Impact factor:   2.899


  78 in total

Review 1.  Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.

Authors:  Juanjuan Chen; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-05-22       Impact factor: 3.622

2.  The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.

Authors:  Liona C Poon; Andrew Shennan; Jonathan A Hyett; Anil Kapur; Eran Hadar; Hema Divakar; Fionnuala McAuliffe; Fabricio da Silva Costa; Peter von Dadelszen; Harold David McIntyre; Anne B Kihara; Gian Carlo Di Renzo; Roberto Romero; Mary D'Alton; Vincenzo Berghella; Kypros H Nicolaides; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2019-05       Impact factor: 3.561

Review 3.  Monitoring and evaluation of out-of-office blood pressure during pregnancy.

Authors:  Hirohito Metoki; Noriyuki Iwama; Mami Ishikuro; Michihiro Satoh; Takahisa Murakami; Hidekazu Nishigori
Journal:  Hypertens Res       Date:  2016-08-25       Impact factor: 3.872

4.  Polymorphisms in complement genes and risk of preeclampsia in Taiyuan, China.

Authors:  Weiwei Wu; Hailan Yang; Yongliang Feng; Ping Zhang; Shuzhen Li; Xin Wang; Tingting Peng; Fang Wang; Bingjie Xie; Pengge Guo; Mei Li; Ying Wang; Nan Zhao; Dennis Wang; Suping Wang; Yawei Zhang
Journal:  Inflamm Res       Date:  2016-07-12       Impact factor: 4.575

Review 5.  First trimester screening for pre-eclampsia.

Authors:  Stefan C Kane
Journal:  Obstet Med       Date:  2016-05-14

Review 6.  Comparative risks and predictors of preeclamptic pregnancy in the Eastern, Western and developing world.

Authors:  Ning Zhang; Jing Tan; HaiFeng Yang; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2020-09-25       Impact factor: 5.858

Review 7.  Calcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancy.

Authors:  G Justus Hofmeyr; Sarah Manyame
Journal:  Cochrane Database Syst Rev       Date:  2017-09-26

8.  Antepartum Care of Women Who Are Obese During Pregnancy: Systematic Review of the Current Evidence.

Authors:  Nicole S Carlson; Sharon Lynn Leslie; Alexis Dunn
Journal:  J Midwifery Womens Health       Date:  2018-05-14       Impact factor: 2.388

9.  Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia.

Authors:  J S Possomato-Vieira; R A Khalil
Journal:  Adv Pharmacol       Date:  2016-06-14

Review 10.  Precision test for precision medicine: opportunities, challenges and perspectives regarding pre-eclampsia as an intervention window for future cardiovascular disease.

Authors:  Xin Zhou; Jian-Min Niu; Wen-Jie Ji; Zhuoli Zhang; Peizhong P Wang; Xue-Feng B Ling; Yu-Ming Li
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.